Form 8-K - Current report:
SEC Accession No. 0000950170-25-099631
Filing Date
2025-07-29
Accepted
2025-07-29 16:10:34
Documents
58
Period of Report
2025-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20250729.htm   iXBRL 8-K 48002
2 EX-99.1 crdf-ex99_1.htm EX-99.1 256780
3 EX-99.2 crdf-ex99_2.htm EX-99.2 57212
4 PDF COURTESY COPY crdf-ex99_2.pdf EX-99.2 7609536
5 EX-99.3 crdf-ex99_3.htm EX-99.3 46995
6 GRAPHIC img186708884_0.jpg GRAPHIC 14426
7 GRAPHIC img188555926_0.jpg GRAPHIC 19987
8 GRAPHIC img188555926_1.jpg GRAPHIC 313621
9 GRAPHIC crdf-ex99_2s1.jpg GRAPHIC 231767
10 GRAPHIC crdf-ex99_2s2.jpg GRAPHIC 522576
11 GRAPHIC crdf-ex99_2s3.jpg GRAPHIC 126716
12 GRAPHIC crdf-ex99_2s4.jpg GRAPHIC 236721
13 GRAPHIC crdf-ex99_2s5.jpg GRAPHIC 200216
14 GRAPHIC crdf-ex99_2s6.jpg GRAPHIC 381323
15 GRAPHIC crdf-ex99_2s7.jpg GRAPHIC 124455
16 GRAPHIC crdf-ex99_2s8.jpg GRAPHIC 171738
17 GRAPHIC crdf-ex99_2s9.jpg GRAPHIC 261963
18 GRAPHIC crdf-ex99_2s10.jpg GRAPHIC 272724
19 GRAPHIC crdf-ex99_2s11.jpg GRAPHIC 296804
20 GRAPHIC crdf-ex99_2s12.jpg GRAPHIC 209616
21 GRAPHIC crdf-ex99_2s13.jpg GRAPHIC 231655
22 GRAPHIC crdf-ex99_2s14.jpg GRAPHIC 313525
23 GRAPHIC crdf-ex99_2s15.jpg GRAPHIC 364773
24 GRAPHIC crdf-ex99_2s16.jpg GRAPHIC 271546
25 GRAPHIC crdf-ex99_2s17.jpg GRAPHIC 398860
26 GRAPHIC crdf-ex99_2s18.jpg GRAPHIC 375439
27 GRAPHIC crdf-ex99_2s19.jpg GRAPHIC 398858
28 GRAPHIC crdf-ex99_2s20.jpg GRAPHIC 352113
29 GRAPHIC crdf-ex99_2s21.jpg GRAPHIC 293368
30 GRAPHIC crdf-ex99_2s22.jpg GRAPHIC 219799
31 GRAPHIC crdf-ex99_2s23.jpg GRAPHIC 155045
32 GRAPHIC crdf-ex99_2s24.jpg GRAPHIC 246022
33 GRAPHIC crdf-ex99_2s25.jpg GRAPHIC 335366
34 GRAPHIC crdf-ex99_2s26.jpg GRAPHIC 312468
35 GRAPHIC crdf-ex99_2s27.jpg GRAPHIC 291861
36 GRAPHIC crdf-ex99_2s28.jpg GRAPHIC 294439
37 GRAPHIC crdf-ex99_2s29.jpg GRAPHIC 161994
38 GRAPHIC crdf-ex99_2s30.jpg GRAPHIC 205821
39 GRAPHIC crdf-ex99_2s31.jpg GRAPHIC 249299
40 GRAPHIC crdf-ex99_2s32.jpg GRAPHIC 220389
41 GRAPHIC crdf-ex99_2s33.jpg GRAPHIC 217501
42 GRAPHIC crdf-ex99_2s34.jpg GRAPHIC 256544
43 GRAPHIC crdf-ex99_2s35.jpg GRAPHIC 91996
44 GRAPHIC crdf-ex99_2s36.jpg GRAPHIC 299267
45 GRAPHIC crdf-ex99_2s37.jpg GRAPHIC 287435
46 GRAPHIC crdf-ex99_2s38.jpg GRAPHIC 229352
47 GRAPHIC crdf-ex99_2s39.jpg GRAPHIC 257663
48 GRAPHIC crdf-ex99_2s40.jpg GRAPHIC 233740
49 GRAPHIC crdf-ex99_2s41.jpg GRAPHIC 500593
  Complete submission text file 0000950170-25-099631.txt   26797819

Data Files

Seq Description Document Type Size
50 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crdf-20250729.xsd EX-101.SCH 23903
60 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20250729_htm.xml XML 4500
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 251161960
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)